Immunotherapy in allergic respiratory diseases. 1990

D Vervloet, and X van der Brempt, and D Charpin, and J Birnbaum
Département des Maladies Respiratoires, Hôpital Sainte-Marguerite, Marseille, France.

Much more work is needed to specify the correct indications for immunotherapy in respiratory allergic diseases. Immunotherapy with pollen and mite extracts has shown some clinical efficacy versus placebo in controlled studies in allergic rhinitis and/or asthma. However, controlled studies comparing the cost, the risk factors and the efficacy of immunotherapy versus treatment with antihistaminic drugs, bronchodilators and topical steroids are needed. Additional studies are needed to established the place of immunotherapy in animal danders and mould allergy. In any case, before initiating immunotherapy in respiratory allergy the following questions must be answered: is there sufficient evidence of a close relationship between symptoms and allergen exposure? is it possible to achieve efficient allergen avoidance? is simple drug treatment no sufficient? is there evidence in the literature of effectiveness of IT for this allergen? is the patient able to comply with a long and constraining treatment?

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D012130 Respiratory Hypersensitivity A form of hypersensitivity affecting the respiratory tract. It includes ASTHMA and RHINITIS, ALLERGIC, SEASONAL. Airway Hyperresponsiveness,Hypersensitivity, Respiratory,Airway Hyper-Responsiveness,Airway Hyper Responsiveness,Airway Hyperresponsivenesses,Hyper-Responsiveness, Airway,Hyperresponsiveness, Airway,Respiratory Hypersensitivities
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen

Related Publications

D Vervloet, and X van der Brempt, and D Charpin, and J Birnbaum
October 2012, Human vaccines & immunotherapeutics,
D Vervloet, and X van der Brempt, and D Charpin, and J Birnbaum
November 2023, Allergy and asthma proceedings,
D Vervloet, and X van der Brempt, and D Charpin, and J Birnbaum
October 2020, Minerva pediatrica,
D Vervloet, and X van der Brempt, and D Charpin, and J Birnbaum
February 1998, The Journal of allergy and clinical immunology,
D Vervloet, and X van der Brempt, and D Charpin, and J Birnbaum
December 1993, Allergie et immunologie,
D Vervloet, and X van der Brempt, and D Charpin, and J Birnbaum
May 2011, Immunology and allergy clinics of North America,
D Vervloet, and X van der Brempt, and D Charpin, and J Birnbaum
September 2022, Clinical and experimental immunology,
D Vervloet, and X van der Brempt, and D Charpin, and J Birnbaum
January 2001, International journal of immunopathology and pharmacology,
D Vervloet, and X van der Brempt, and D Charpin, and J Birnbaum
May 2012, Chest,
D Vervloet, and X van der Brempt, and D Charpin, and J Birnbaum
February 2010, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!